Remove Clinical Trials Remove Data Remove Terpenes
article thumbnail

CBD Topical Medicine: What Does the Science Say?

Project CBD

Such products rely on chemical enhancers (called excipients) like ethanol, propylene glycol, oleic acid, and even terpenes to help cannabinoids sneak past the skin barrier and into the bloodstream. Ultimately, they concluded that the available data on pain and other outcomes was unreliable, with a high risk of bias.

Topical 179
article thumbnail

South African Research Team Says Cannabis is ‘Very Promising’ as an Opioid Replacement

Veriheal

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. We are currently recruiting patients, and data-capturing all the questionnaires and feedback from the patients for the live study. Quite frankly, the clinical trials couldn’t have come at a better time.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Here’s what you need to know about cannabis research

The Cannigma

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. However, a result can be statistically significant but not clinically significant–meaning that even though a study may detect a difference on paper, it may make no tangible difference in real-world application.

article thumbnail

Getting to Know Cannabigerol with Bonni Goldstein, MD

Project CBD

It’s noteworthy that much of this anecdotal data is supported by findings from preclinical research. Dr. Goldstein: We don’t have clinical trials to say, yes this is definitively beneficial or detrimental for children. But we may be on the cusp of having those trials, which would be very exciting.

article thumbnail

New U.S. Research Efforts Could Catalyze Medical Cannabis’ Adoption in the Pharmaceutical Industry

Veriheal

We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. This means that U.S.

article thumbnail

Israel’s Tikun Olam Making Moves in the U.S. and Canada

Freedom Leaf

“We’re actively working toward developing new genetics to work on efficacy and assist the patients in Israel still operating with our nurse-run clinics in order to better provide the right dosage and strains for the patients who are referred to us by the Ministry of Health,” Stephen Gardner, Tikun Olam’s chief marketing officer, tells Freedom Leaf.

article thumbnail

Study: Cannabis Associated With Reduced ADHD Mediciation Use

The Joint Blog

Clinical trial data published in 2017 in in the journal European Neuropsychopharmacology previously reported that the administration of whole-plant cannabis extracts is associated with improvements in cognition and behavior in subjects with ADHD. 9-tetrahydrocannabinol (THC).